Statins and diabetes mellitus: price of collaboration

It is now well established that clinical use of statins for primary and secondary prevention of cardiovascular complications in patientswith diabetes mellitus (DM) increases life expectancy. At the same time, meta-analysis of major randomized trials shows statins to increaseglycemic levels and incid...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Andrey Alexeevich Aleksandrov, Maria Nikolaevna Yadrikhinskaya, Svetlana Semenovna Kukharenko, Olga Alexandrovna Shatskaya
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	statins glycemic disorders diabetes mellitus cardiovascular complications dyslipidemia Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/d1621016038b4a5abe471d23edeb8a2c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d1621016038b4a5abe471d23edeb8a2c
record_format	dspace
spelling	oai:doaj.org-article:d1621016038b4a5abe471d23edeb8a2c2021-11-14T09:00:17ZStatins and diabetes mellitus: price of collaboration2072-03512072-037810.14341/2072-0351-5522https://doaj.org/article/d1621016038b4a5abe471d23edeb8a2c2012-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5522https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378It is now well established that clinical use of statins for primary and secondary prevention of cardiovascular complications in patientswith diabetes mellitus (DM) increases life expectancy. At the same time, meta-analysis of major randomized trials shows statins to increaseglycemic levels and incidence of diabetic symptoms, especially in patients at risk for developing glycemic disorders. However,comparison of positive and negative effects of statins suggests prevalence of clinically beneficial factors.Andrey Alexeevich AleksandrovMaria Nikolaevna YadrikhinskayaSvetlana Semenovna KukharenkoOlga Alexandrovna ShatskayaEndocrinology Research Centrearticlestatinsglycemic disordersdiabetes mellituscardiovascular complicationsdyslipidemiaNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 2, Pp 70-76 (2012)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	statins glycemic disorders diabetes mellitus cardiovascular complications dyslipidemia Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	statins glycemic disorders diabetes mellitus cardiovascular complications dyslipidemia Nutritional diseases. Deficiency diseases RC620-627 Andrey Alexeevich Aleksandrov Maria Nikolaevna Yadrikhinskaya Svetlana Semenovna Kukharenko Olga Alexandrovna Shatskaya Statins and diabetes mellitus: price of collaboration
description	It is now well established that clinical use of statins for primary and secondary prevention of cardiovascular complications in patientswith diabetes mellitus (DM) increases life expectancy. At the same time, meta-analysis of major randomized trials shows statins to increaseglycemic levels and incidence of diabetic symptoms, especially in patients at risk for developing glycemic disorders. However,comparison of positive and negative effects of statins suggests prevalence of clinically beneficial factors.
format	article
author	Andrey Alexeevich Aleksandrov Maria Nikolaevna Yadrikhinskaya Svetlana Semenovna Kukharenko Olga Alexandrovna Shatskaya
author_facet	Andrey Alexeevich Aleksandrov Maria Nikolaevna Yadrikhinskaya Svetlana Semenovna Kukharenko Olga Alexandrovna Shatskaya
author_sort	Andrey Alexeevich Aleksandrov
title	Statins and diabetes mellitus: price of collaboration
title_short	Statins and diabetes mellitus: price of collaboration
title_full	Statins and diabetes mellitus: price of collaboration
title_fullStr	Statins and diabetes mellitus: price of collaboration
title_full_unstemmed	Statins and diabetes mellitus: price of collaboration
title_sort	statins and diabetes mellitus: price of collaboration
publisher	Endocrinology Research Centre
publishDate	2012
url	https://doaj.org/article/d1621016038b4a5abe471d23edeb8a2c
work_keys_str_mv	AT andreyalexeevichaleksandrov statinsanddiabetesmellituspriceofcollaboration AT marianikolaevnayadrikhinskaya statinsanddiabetesmellituspriceofcollaboration AT svetlanasemenovnakukharenko statinsanddiabetesmellituspriceofcollaboration AT olgaalexandrovnashatskaya statinsanddiabetesmellituspriceofcollaboration
_version_	1718429615632941056

Statins and diabetes mellitus: price of collaboration

Ejemplares similares